Position in ZTS
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$12,808,880
+$151,388 QoQ
Shares Held
108,357
+7.7% QoQ
Ownership
0.026%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Ensign Peak Advisors, Inc holds $59,723,780 across 18 Drug Manufacturers - Specialty & Generic names. ZTS ranks #3 (21.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
181,481 | $23,908,306 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
25,292 | $14,997,650 | |
| 3 | ZTS |
Zoetis Inc.
This page
|
108,357 | $12,808,880 | |
| 4 | BIOA |
BioAge Labs, Inc.
|
166,224 | $2,907,257 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
40,850 | $1,230,402 | |
| 6 | VTRS |
Viatris Inc
|
65,686 | $887,417 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
31,510 | $754,034 | |
| 8 | PBH |
Prestige Consumer Healthcare Inc.
|
5,785 | $342,876 |
All Filings in ZTS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $12,808,880 | 108,357 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $12,657,492 | 100,600 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $15,569,911 | 106,410 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $17,170,095 | 110,100 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $19,970,892 | 121,293 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $47,716,168 | 292,863 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $72,514,700 | 371,147 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $68,852,351 | 397,164 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $73,158,281 | 432,352 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $79,871,691 | 404,680 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $59,109,878 | 339,751 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $59,249,539 | 344,054 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $55,907,196 | 335,900 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $46,780,518 | 319,212 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $41,694,847 | 281,171 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $41,000,406 | 238,527 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $48,053,674 | 254,805 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $67,845,220 | 278,020 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $47,383,749 | 244,070 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $41,391,860 | 222,107 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $35,922,605 | 228,109 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $27,968,672 | 168,995 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $52,457,844 | 317,215 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $36,723,019 | 267,973 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $28,688,467 | 243,763 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||